LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.474
EU - Europa 9.530
AS - Asia 1.179
SA - Sud America 47
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 22.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.401
IT - Italia 4.178
GB - Regno Unito 2.839
SE - Svezia 734
DE - Germania 514
CN - Cina 484
UA - Ucraina 327
HK - Hong Kong 275
FI - Finlandia 236
FR - Francia 229
TR - Turchia 214
BG - Bulgaria 140
IN - India 62
SG - Singapore 62
RU - Federazione Russa 51
BE - Belgio 47
CA - Canada 45
AL - Albania 39
RO - Romania 32
IE - Irlanda 26
NL - Olanda 26
VN - Vietnam 25
MY - Malesia 22
MX - Messico 19
ES - Italia 17
PL - Polonia 17
BR - Brasile 16
CH - Svizzera 15
AR - Argentina 14
LV - Lettonia 14
PT - Portogallo 9
IR - Iran 8
CL - Cile 7
CZ - Repubblica Ceca 6
GR - Grecia 6
JP - Giappone 6
KR - Corea 6
BZ - Belize 5
IL - Israele 5
NO - Norvegia 5
PE - Perù 5
AT - Austria 3
AU - Australia 3
DK - Danimarca 3
EU - Europa 3
GT - Guatemala 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
EC - Ecuador 2
HU - Ungheria 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
HN - Honduras 1
LK - Sri Lanka 1
LT - Lituania 1
MK - Macedonia 1
MT - Malta 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
Totale 22.240
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Fairfield 1.665
Woodbridge 1.129
Chandler 940
Ashburn 863
Houston 800
Jacksonville 676
Seattle 651
Cambridge 591
Wilmington 577
Dearborn 574
Ann Arbor 532
Nyköping 485
Rome 326
Modena 296
Hong Kong 273
Milan 190
Beijing 182
San Diego 175
Princeton 157
Izmir 143
Sofia 135
Eugene 130
Helsinki 126
New York 112
Bremen 77
Naples 71
Turin 67
Bologna 62
Palermo 62
Des Moines 59
London 55
Cagliari 51
Redwood City 51
Bari 50
Frankfurt am Main 50
Fremont 47
Shanghai 44
Parma 41
Florence 40
Verona 39
Brussels 35
Falls Church 33
Perugia 30
Tirana 29
Boardman 28
Napoli 28
Catania 27
Genoa 27
Nanjing 26
Padova 25
Dublin 24
Pescara 24
Reggio Emilia 24
Dong Ket 22
Hefei 22
Toronto 22
Hounslow 19
Kilburn 19
Trieste 19
Kunming 18
Ottawa 18
San Giuliano Milanese 18
Brescia 17
Grafing 16
Phoenix 16
Piacenza 16
Chicago 14
Chieti 14
Chiswick 14
Monza 13
Norwalk 13
Pisa 13
Taranto 12
San Mateo 11
Augusta 10
Bagheria 10
Guangzhou 10
Indiana 10
Pavia 10
Reggio Calabria 10
Romainville 10
Saint Petersburg 10
Salerno 10
Siena 10
Trento 10
Udine 10
Buenos Aires 9
Ferrara 9
Imola 9
Madrid 9
Montecatini Terme 9
Mountain View 9
Paris 9
Torino 9
Ferrara di Monte Baldo 8
Legnano 8
Monmouth Junction 8
Pesaro 8
Portici 8
Totale 16.028
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 3.473
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 295
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 286
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 275
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 248
Repurposing of drugs targeting yap-tead functions 241
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 223
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 221
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. 217
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 212
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 210
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 206
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 200
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 196
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 194
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 190
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 189
Desmoplastic melanoma: a challenge for the oncologist 188
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 187
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 186
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 186
Aetiology of colorectal cancer and relevance of monogenic inheritance. 185
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 184
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 184
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 180
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 180
Microsatellite instability and colorectal cancer prognosis. 177
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 177
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 177
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 176
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 176
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 172
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 172
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 171
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 168
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 167
Aberrant crypt foci in patients with colorectal cancer 163
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 162
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 162
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 162
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 161
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 160
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 160
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes. 160
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 159
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 159
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 159
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 158
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 157
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 156
K-ras and p53 mutations in human colorectal aberrant crypt foci 153
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 153
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 151
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 151
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 151
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 150
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 150
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 148
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 147
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 147
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 146
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 146
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 143
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 140
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 140
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 140
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 139
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 138
Expression of p53 protein in prostate cancers of different histologic types. 138
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 137
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 137
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 135
Microsatellite instability in multiple colorectal tumors 135
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 134
Prognostic significance of K-ras mutations in colorectal carcinoma. 132
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 131
Survival for colon and rectal cancer in a population-based cancer registry 131
Myxoid metastases of melanoma: report of three cases and review of the literature 130
Histology of aberrant crypt foci in the human colon 130
Ventricular Arrhythmias After Intramyocardial Administration of Mesenchymal Bone Marrow Stem Cells in Acute Myocardial Infarction: An Animal Model 124
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 122
Paneth and argyrophil cells in prostatic carcinoma. 121
Colorectal carcinoma in different age groups: A population based investigation 121
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 120
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 120
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 119
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 119
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 118
Cell kinetics evaluation of colorectal tumours after in vivo administration of bromodeoxyuridine 113
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 112
Biological characterization of mucinous carcinoma of the colon and rectum 111
Pathological findings in perinatal autopsies 109
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 107
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 107
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 106
Low rectal cancer and distance from anal sphincter before and after preoperative therapy 104
Cardiac arrhythmias after intramyocardial administration of mesenchymal bone marrow stem cells in acute myocardial infarction 104
Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer 101
Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacantomas: role of clinical features, microsatellite instability and immunohistochemistry 100
Migration cholécysto-cholédocienne de végétations adénomateuses papillaires 99
Totale 19.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.059
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.059
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.364 0 0 0 0 0 0 0 0 0 290 479 595
2019/20204.710 468 175 138 261 537 649 716 507 555 197 290 217
2020/20213.860 416 140 296 365 397 319 324 474 231 432 243 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20242.866 187 202 247 363 571 310 287 376 152 171 0 0
Totale 22.450